Where a prescriber-first pass-through platform fits between the two
The RxFul-versus-direct-portal choice is patient-brand breadth versus prescriber-depth, but it leaves a third option out: a prescriber-first pass-through platform. RxFul centers patient checkout; a direct portal centers one compounder's prescriber workflow. Neither shows resolved per-vial 503A landed cost across every assigned partner at the moment your team is quoting a patient on refill day.
Fizy Health takes the breadth of a multi-pharmacy platform on the prescriber side and adds pass-through pricing: per-vial cost on each catalog and cart line before checkout, with a disclosed facilitation fee at payment. It batches every patient into one clinic cart, validates SIGs and licensure before you pay, and routes each line to the right LegitScript-certified 503A partner automatically. If your real decision is patient portal versus direct prescriber portal and you also need price-before-quote and pre-payment validation, that is the wedge neither RxFul nor a single LifeFile portal fills.